Global Contraceptive Drugs and Devices Market Overview And Scope:
Global Contraceptive Drugs and Devices Market Size was estimated at USD 6829.47 million in 2022 and is projected to reach USD 8865.19 million by 2028, exhibiting a CAGR of 4.44% during the forecast period.
The Global Contraceptive Drugs and Devices Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Contraceptive Drugs and Devices utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Top Key Players Mentioned Are: Bayer Healthcare, Merck, Church and Dwight, Warmer Chilcott, Agile Therapeutics, Pfizer, BioSante Pharmaceuticals, Mayer Laboratories, Pantarhei Bioscience, Teva Pharmaceutical Industries
Global Contraceptive Drugs and Devices Market Segmentation
By Type, Contraceptive Drugs and Devices market has been segmented into:Oral
Vaginal
Injectable Contraceptive Drugs
Male/Female Contraceptive Devices
By Application, Contraceptive Drugs and Devices market has been segmented into:
Hospitals
Pharmacies
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Contraceptive Drugs and Devices market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Contraceptive Drugs and Devices market.
Top Key Players Covered in Contraceptive Drugs and Devices market are:
Bayer Healthcare
Merck
Church and Dwight
Warmer Chilcott
Agile Therapeutics
Pfizer
BioSante Pharmaceuticals
Mayer Laboratories
Pantarhei Bioscience
Teva Pharmaceutical Industries
Objective to buy this Report:
1. Contraceptive Drugs and Devices analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Contraceptive Drugs and Devices market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Contraceptive Drugs and Devices Market by Type
5.1 Contraceptive Drugs and Devices Market Overview Snapshot and Growth Engine
5.2 Contraceptive Drugs and Devices Market Overview
5.3 Oral
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Oral: Geographic Segmentation
5.4 Vaginal
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Vaginal: Geographic Segmentation
5.5 Injectable Contraceptive Drugs
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Injectable Contraceptive Drugs: Geographic Segmentation
5.6 Male/Female Contraceptive Devices
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Male/Female Contraceptive Devices: Geographic Segmentation
Chapter 6: Contraceptive Drugs and Devices Market by Application
6.1 Contraceptive Drugs and Devices Market Overview Snapshot and Growth Engine
6.2 Contraceptive Drugs and Devices Market Overview
6.3 Hospitals
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospitals: Geographic Segmentation
6.4 Pharmacies
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Pharmacies: Geographic Segmentation
6.5 Others
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Others: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Contraceptive Drugs and Devices Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Contraceptive Drugs and Devices Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Contraceptive Drugs and Devices Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 BAYER HEALTHCARE
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 MERCK
7.4 CHURCH AND DWIGHT
7.5 WARMER CHILCOTT
7.6 AGILE THERAPEUTICS
7.7 PFIZER
7.8 BIOSANTE PHARMACEUTICALS
7.9 MAYER LABORATORIES
7.10 PANTARHEI BIOSCIENCE
7.11 TEVA PHARMACEUTICAL INDUSTRIES
Chapter 8: Global Contraceptive Drugs and Devices Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Oral
8.2.2 Vaginal
8.2.3 Injectable Contraceptive Drugs
8.2.4 Male/Female Contraceptive Devices
8.3 Historic and Forecasted Market Size By Application
8.3.1 Hospitals
8.3.2 Pharmacies
8.3.3 Others
Chapter 9: North America Contraceptive Drugs and Devices Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Oral
9.4.2 Vaginal
9.4.3 Injectable Contraceptive Drugs
9.4.4 Male/Female Contraceptive Devices
9.5 Historic and Forecasted Market Size By Application
9.5.1 Hospitals
9.5.2 Pharmacies
9.5.3 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Contraceptive Drugs and Devices Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Oral
10.4.2 Vaginal
10.4.3 Injectable Contraceptive Drugs
10.4.4 Male/Female Contraceptive Devices
10.5 Historic and Forecasted Market Size By Application
10.5.1 Hospitals
10.5.2 Pharmacies
10.5.3 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Contraceptive Drugs and Devices Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Oral
11.4.2 Vaginal
11.4.3 Injectable Contraceptive Drugs
11.4.4 Male/Female Contraceptive Devices
11.5 Historic and Forecasted Market Size By Application
11.5.1 Hospitals
11.5.2 Pharmacies
11.5.3 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Contraceptive Drugs and Devices Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Oral
12.4.2 Vaginal
12.4.3 Injectable Contraceptive Drugs
12.4.4 Male/Female Contraceptive Devices
12.5 Historic and Forecasted Market Size By Application
12.5.1 Hospitals
12.5.2 Pharmacies
12.5.3 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Contraceptive Drugs and Devices Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Oral
13.4.2 Vaginal
13.4.3 Injectable Contraceptive Drugs
13.4.4 Male/Female Contraceptive Devices
13.5 Historic and Forecasted Market Size By Application
13.5.1 Hospitals
13.5.2 Pharmacies
13.5.3 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Contraceptive Drugs and Devices Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Oral
14.4.2 Vaginal
14.4.3 Injectable Contraceptive Drugs
14.4.4 Male/Female Contraceptive Devices
14.5 Historic and Forecasted Market Size By Application
14.5.1 Hospitals
14.5.2 Pharmacies
14.5.3 Others
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Contraceptive Drugs and Devices Scope:
|
Report Data
|
Contraceptive Drugs and Devices Market
|
|
Contraceptive Drugs and Devices Market Size in 2025
|
USD XX million
|
|
Contraceptive Drugs and Devices CAGR 2025 - 2032
|
XX%
|
|
Contraceptive Drugs and Devices Base Year
|
2024
|
|
Contraceptive Drugs and Devices Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Bayer Healthcare, Merck, Church and Dwight, Warmer Chilcott, Agile Therapeutics, Pfizer, BioSante Pharmaceuticals, Mayer Laboratories, Pantarhei Bioscience, Teva Pharmaceutical Industries.
|
|
Key Segments
|
By Type
Oral
Vaginal
Injectable Contraceptive Drugs
Male/Female Contraceptive Devices
By Applications
Hospitals
Pharmacies
Others
|
